• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性肝细胞癌切除术后复发预测模型的建立与验证

Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection.

作者信息

Xu Yang, Han Huimin, Cao Wei, Fu Hongxing, Liu Yang, Yan Li, Qin Tingting

机构信息

Department of Integrated Traditional Chinese and Western Medicine, Wuhan Third Hospital, Wuhan, China.

Department of Traditional Chinese Medicine, Wuhan Third Hospital, Wuhan, China.

出版信息

J Gastrointest Oncol. 2023 Feb 28;14(1):278-286. doi: 10.21037/jgo-22-1303. Epub 2023 Feb 15.

DOI:10.21037/jgo-22-1303
PMID:36915435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10007949/
Abstract

BACKGROUND

In recent years, nomogram prediction models have been widely used to evaluate the prognosis of various diseases. However, studies in primary hepatocellular carcinoma (HCC) are limited. This study sought to explore the risk factors of recurrence of patients with primary HCC after surgical resection and establish a nomogram prediction model.

METHODS

The data of 424 patients with primary HCC who had been admitted to the Wuhan Third Hospital were retrospectively collected. The patients were followed-up for 5 years after surgery. The patients were divided into the recurrence group (n=189) and control group (n=235) according to whether the cancer recurred after surgery. The differences in the clinical characteristics between the two groups were analyzed. The risk factors of recurrence after surgical resection of primary HCC were also analyzed, and a prediction model was then established using R4.0.3 statistical software.

RESULTS

There were significant statistical differences between the two groups in terms of the tumor size, systemic immune-inflammation (SII) index, the number of lesions, tumor differentiation degree, ascites, vascular invasion, and portal vein tumor thrombus (P<0.05). The multivariate regression analysis showed that multiple foci, poorly differentiated tumors, ascites, vascular invasion, and portal vein tumor thrombus were risk factors for the recurrence of primary HCC in patients after surgical resection (P<0.05). The data set was randomly divided into a training set and verification set. The sample size of the training set was 297, and the sample size of the verification set was 127. The area under the receiver operating characteristic (ROC) curve of the training set was 0.866 [95% confidence interval (CI): 0.824-0.907], and the area under the ROC curve of the validation set was 0.812 (95% CI: 0.734-0.890). The Hosmer-Lemeshow Goodness-of-Fit Test was used to test the model with the validation set (χ=11.243, P=0.188), which indicated that the model had high value in predicting the recurrence of primary HCC after surgical resection.

CONCLUSIONS

This model had high value in predicting the recurrence of primary HCC in patients after surgical resection. This model could assist clinicians to assess the prognosis of patients. Intensive treatment for high-risk patients might improve the prognosis of patients.

摘要

背景

近年来,列线图预测模型已被广泛用于评估各种疾病的预后。然而,关于原发性肝细胞癌(HCC)的研究有限。本研究旨在探讨原发性HCC患者手术切除后复发的危险因素,并建立列线图预测模型。

方法

回顾性收集武汉市第三医院收治的424例原发性HCC患者的数据。术后对患者进行5年随访。根据术后癌症是否复发,将患者分为复发组(n = 189)和对照组(n = 235)。分析两组患者临床特征的差异。分析原发性HCC手术切除后复发的危险因素,然后使用R4.0.3统计软件建立预测模型。

结果

两组在肿瘤大小、全身免疫炎症(SII)指数、病灶数量、肿瘤分化程度、腹水、血管侵犯和门静脉癌栓方面存在显著统计学差异(P < 0.05)。多因素回归分析显示,多发病灶、低分化肿瘤、腹水、血管侵犯和门静脉癌栓是原发性HCC患者手术切除后复发的危险因素(P < 0.05)。将数据集随机分为训练集和验证集。训练集样本量为297,验证集样本量为127。训练集的受试者工作特征(ROC)曲线下面积为0.866 [95%置信区间(CI):0.824 - 0.907],验证集的ROC曲线下面积为0.812(95% CI:0.734 - 0.890)。使用Hosmer-Lemeshow拟合优度检验对验证集进行模型检验(χ = 11.243,P = 0.188),表明该模型在预测原发性HCC手术切除后复发方面具有较高价值。

结论

该模型在预测原发性HCC患者手术切除后复发方面具有较高价值。该模型可协助临床医生评估患者预后。对高危患者进行强化治疗可能改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/2f2c50b4b8b1/jgo-14-01-278-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/715b5bef73aa/jgo-14-01-278-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/cda421a37db1/jgo-14-01-278-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/e93c28e58da5/jgo-14-01-278-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/e7c2c450165f/jgo-14-01-278-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/2f2c50b4b8b1/jgo-14-01-278-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/715b5bef73aa/jgo-14-01-278-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/cda421a37db1/jgo-14-01-278-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/e93c28e58da5/jgo-14-01-278-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/e7c2c450165f/jgo-14-01-278-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36db/10007949/2f2c50b4b8b1/jgo-14-01-278-f5.jpg

相似文献

1
Establishment and validation of a predictive model of recurrence in primary hepatocellular carcinoma after resection.原发性肝细胞癌切除术后复发预测模型的建立与验证
J Gastrointest Oncol. 2023 Feb 28;14(1):278-286. doi: 10.21037/jgo-22-1303. Epub 2023 Feb 15.
2
Establishment and validation of a long-term prognosis prediction model for patients with non-small cell lung cancer.非小细胞肺癌患者长期预后预测模型的建立与验证
J Thorac Dis. 2023 Apr 28;15(4):1994-2002. doi: 10.21037/jtd-23-381. Epub 2023 Apr 24.
3
A new model based on gamma-glutamyl transpeptidase to lymphocyte ratio and systemic immune-inflammation index can effectively predict the recurrence of hepatocellular carcinoma after liver transplantation.一种基于γ-谷氨酰转肽酶与淋巴细胞比值及全身免疫炎症指数的新模型能够有效预测肝移植术后肝细胞癌的复发。
Front Oncol. 2023 Apr 20;13:1178123. doi: 10.3389/fonc.2023.1178123. eCollection 2023.
4
[The study of nomogram based on Ishak inflammation score for recurrence of hepatocellular carcinoma after curative resection].基于Ishak炎症评分的列线图对肝细胞癌根治性切除术后复发的研究
Zhonghua Wai Ke Za Zhi. 2018 Feb 1;56(2):124-129. doi: 10.3760/cma.j.issn.0529-5815.2018.02.009.
5
Nomogram for prediction of hepatocellular carcinoma recurrence after liver resection.肝切除术后肝细胞癌复发预测列线图
Hepatobiliary Pancreat Dis Int. 2025 Jun;24(3):269-276. doi: 10.1016/j.hbpd.2024.09.006. Epub 2024 Sep 19.
6
Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.新型模型预测乙型肝炎病毒相关≤10cm 单发肝细胞癌且无门静脉癌栓患者的术后复发和总生存期。
Oncologist. 2020 Oct;25(10):e1552-e1561. doi: 10.1634/theoncologist.2019-0766. Epub 2020 Aug 6.
7
[Establishment and validation of a predictive nomogram model for advanced gastric cancer with perineural invasion].[伴有神经侵犯的进展期胃癌预测列线图模型的建立与验证]
Zhonghua Wei Chang Wai Ke Za Zhi. 2020 Nov 25;23(11):1059-1066. doi: 10.3760/cma.j.cn.441530-20200103-00004.
8
Development of a novel prognostic nomogram for the early recurrence of liver cancer after curative hepatectomy.一种用于预测肝癌根治性肝切除术后早期复发的新型预后列线图的开发。
Ann Transl Med. 2021 Oct;9(20):1541. doi: 10.21037/atm-21-4837.
9
[The clinical value of serum GPC3 level in predicting recurrence of patients with primary hepatocellular carcinoma].血清GPC3水平在预测原发性肝细胞癌患者复发中的临床价值
Zhonghua Yu Fang Yi Xue Za Zhi. 2023 Jun 6;57(6):885-890. doi: 10.3760/cma.j.cn112150-20221111-01098.
10
Prediction of bile duct injury after transarterial chemoembolization for hepatocellular carcinoma: Model establishment and verification.肝细胞癌经动脉化疗栓塞术后胆管损伤的预测:模型建立与验证
Front Oncol. 2022 Dec 16;12:973045. doi: 10.3389/fonc.2022.973045. eCollection 2022.

引用本文的文献

1
Adjuvant Lenvatinib for High-Risk CNLC IIb/IIIa Hepatocellular Carcinoma After Curative Hepatectomy: A Prospective Exploratory Study.根治性肝切除术后辅助使用乐伐替尼治疗高危CNLC IIb/IIIa期肝细胞癌:一项前瞻性探索性研究
J Hepatocell Carcinoma. 2025 May 22;12:1043-1056. doi: 10.2147/JHC.S516478. eCollection 2025.
2
Efficacy and factors related to prognosis of combination chemotherapy with different radiotherapy methods in patients with unresectable hepatocellular carcinoma.不可切除肝细胞癌患者不同放疗方法联合化疗的疗效及预后相关因素
Sci Rep. 2025 Apr 7;15(1):11823. doi: 10.1038/s41598-025-91992-z.
3
Prognostic value of preoperative systemic immune-inflammation index/albumin for patients with hepatocellular carcinoma undergoing curative resection.

本文引用的文献

1
A Nomogram for Predicting Liver Metastasis of Lymph-Node Positive Luminal B HER2 Negative Subtype Breast Cancer by Analyzing the Clinicopathological Characteristics of Patients with Breast Cancer.基于乳腺癌患者临床病理特征分析的淋巴结阳性 Luminal B HER2 阴性亚型乳腺癌肝转移预测列线图
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221132669. doi: 10.1177/15330338221132669.
2
A Novel Thoracoabdominal Aorta CTA-based Nomogram Model to Identify Ideal Candidates for Transradial Approach Chemoembolization in Patients with Liver Cancer.一种基于新型胸腹主动脉CT血管造影的列线图模型,用于识别肝癌患者经桡动脉途径化疗栓塞的理想候选者。
J Cancer. 2022 Jul 4;13(9):2863-2871. doi: 10.7150/jca.73678. eCollection 2022.
3
术前全身免疫炎症指数/白蛋白对接受根治性切除的肝细胞癌患者的预后价值
World J Gastroenterol. 2024 Dec 28;30(48):5130-5151. doi: 10.3748/wjg.v30.i48.5130.
4
Construction and validation of a novel prognostic model for intrahepatic cholangiocarcinoma based on a combined scoring system of systemic immune-inflammation index and albumin-bilirubin: a multicenter study.基于全身免疫炎症指数和白蛋白-胆红素联合评分系统构建及验证肝内胆管癌新型预后模型:一项多中心研究
Front Oncol. 2023 Sep 28;13:1239375. doi: 10.3389/fonc.2023.1239375. eCollection 2023.
5
A nomogram for predicting recurrence of primary hepatocellular carcinoma after resection.一种用于预测原发性肝细胞癌切除术后复发的列线图。
J Gastrointest Oncol. 2023 Aug 31;14(4):1900-1901. doi: 10.21037/jgo-23-138. Epub 2023 Jul 5.
miR-887-3p Inhibits the Progression of Colorectal Cancer via Downregulating DNMT1 Expression and Regulating P53 Expression.
miR-887-3p 通过下调 DNMT1 表达和调节 P53 表达抑制结直肠癌细胞的进展。
Comput Intell Neurosci. 2022 Jun 27;2022:7179733. doi: 10.1155/2022/7179733. eCollection 2022.
4
A Practical Nomogram and Risk Stratification System Predicting Cancer-Specific Survival for Hepatocellular Carcinoma Patients With Severe Liver Fibrosis.一种预测重度肝纤维化肝细胞癌患者癌症特异性生存的实用列线图和风险分层系统。
Front Surg. 2022 Jun 16;9:920589. doi: 10.3389/fsurg.2022.920589. eCollection 2022.
5
High Neutrophil-To-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammation Index (SII) Are Markers of Longer Survival After Metastasectomy of Patients With Liver-Only Metastasis of Rectal Cancer.高中性粒细胞与淋巴细胞比值(NLR)和全身免疫炎症指数(SII)是直肠癌仅有肝转移患者转移瘤切除术长期生存的标志物。
Pathol Oncol Res. 2022 Apr 27;28:1610315. doi: 10.3389/pore.2022.1610315. eCollection 2022.
6
Nomogram predicting the cancer-specific survival of early-onset colorectal cancer patients with synchronous liver metastasis: a population-based study.基于人群的研究:预测早发性结直肠癌伴同步肝转移患者癌症特异性生存的列线图。
Int J Colorectal Dis. 2022 Jun;37(6):1309-1319. doi: 10.1007/s00384-022-04175-x. Epub 2022 May 7.
7
Probiotics and synbiotics for preventing postoperative infectious complications in colorectal cancer patients: a systematic review and meta-analysis.益生菌和合生菌预防结直肠癌患者术后感染性并发症的效果:系统评价和荟萃分析。
Tech Coloproctol. 2022 Jun;26(6):425-436. doi: 10.1007/s10151-022-02585-1. Epub 2022 Mar 29.
8
Small Molecule-Induced Differentiation As a Potential Therapy for Liver Cancer.小分子诱导分化作为肝癌潜在的治疗方法。
Adv Sci (Weinh). 2022 May;9(15):e2103619. doi: 10.1002/advs.202103619. Epub 2022 Mar 27.
9
Predicting metachronous liver metastasis in patients with colorectal cancer: development and assessment of a new nomogram.预测结直肠癌患者的肝转移:新列线图的建立与评估。
World J Surg Oncol. 2022 Mar 12;20(1):80. doi: 10.1186/s12957-022-02558-6.
10
Construction and validation of a nomogram for non small cell lung cancer patients with liver metastases based on a population analysis.基于人群分析构建并验证用于非小细胞肺癌伴肝转移患者的列线图。
Sci Rep. 2022 Mar 7;12(1):4011. doi: 10.1038/s41598-022-07978-8.